Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

NCT06465199 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

289

Enrollment

OTHER

Sponsor class

Conditions

Atypical Teratoid/Rhabdoid Tumor
Embryonal Tumor With Multilayered Rosettes
Ewing Sarcoma
Diffuse Intrinsic Pontine Glioma
Osteosarcoma
Neuroblastoma
DIPG Brain Tumor

Interventions

DRUG: Eflornithine (DFMO)
DRUG: AMXT 1501 Dicaprate

Sponsor

Milton S. Hershey Medical Center

Collaborators

[object Object]
[object Object]